[Upd-discuss] patenting genes
Alan Story
a.c.story@ukc.ac.uk
Mon, 20 Mar 2000 16:22:01 +0000 (GMT Standard Time)
Mickey is quite right. Under TRIPS Art. 27 3 a), TRIPS
signatories can exclude "diagnostic, therepeutic and
surgical methods for the treatment of humans or
animals"...but they cannot exclude pharmaceuticals, which
was the main point I was making about compulsory
licenses.
But then, again as Mickey mentions, S. 301 could come down
on such countries with a thump on those countries who don't
do things the U.S. way.
Interestingly, when the U.S. Congress added subsection (c)
to section 287 of the U.S. Patent Act which denied
holders of patents and surgical procedures the
right to sue medical practioners for the
unauthorised use of these procedures in medical
activities (meaning, failure/refusal to pay royalties),
this protection against damages was only given to U.S.
medical practioners and not those practicing medicine
elsewhere.
Cheers
Alan Story
On Mon, 20 Mar 2000 10:08:49 -0500 "Michael H. Davis"
<Michael.Davis@law.csuohio.edu> wrote:
----------------------
Alan Story
Kent Law School
Eliot College
University of Kent
Canterbury Kent UK
CT2 7NS
a.c.story@ukc.ac.uk
Ph. 01227 823316
Fax 01227 827831